Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
4.76%
End price
30.07.24
€5.50
Summary
This prediction ended on 30.07.24 with a price of €5.50. With a performance of 4.76%, the BUY prediction by StockNews_com for Vanda Pharmaceuticals closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | -5.697% | -5.697% | 39.378% |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten